Buy Betapace Online

(Sotalol Hydrochloride)

The active ingredient in Betapace is sotalol hydrochloride.

Betapace’s mechanism of action works by helping control an irregular heartbeat through slowing the heart’s electrical activity. It contains sotalol, which blocks beta-adrenergic receptors to reduce heart rate and also blocks potassium channels in heart cells, which stabilizes the heart’s electrical signals. Together, these actions help prevent irregular or rapid heartbeats and maintain a more regular heart rhythm.

It is classified as both a Class II (beta-adrenoreceptor blocking) and Class III (cardiac action potential duration prolongation) antiarrhythmic drug.

Follow all directions given to you by your doctor and read all documents provided, including the full Prescribing Information, FDA-Approved Product Labeling, Instructions for Use, and Medication Guide before using Betapace. However, the following is a synopsis of the general guidelines for the use of Betapace:

• Betapace is taken by mouth as tablets or an oral solution.
• It is usually taken once or twice daily, depending on your condition and kidney function.
• Doses should be taken at the same times each day to maintain a steady heart rhythm.
• You may take Betapace with or without food, but try to be consistent.
• Antacids containing magnesium hydroxide or aluminum should not be taken within two hours of Betapace, as they can reduce absorption.
• Your healthcare provider may monitor your ECG, blood pressure, heart rate, serum potassium, and kidney function during treatment.
• Do not skip doses or stop the medication suddenly unless instructed by your healthcare provider. Try not to miss any doses. If you miss a dose, skip the missed dose. Then, take your next dose when you normally would. Do not take double or extra doses.
• If you miss a dose, take it as soon as you remember, unless it is close to the next dose. Do not double the next dose.

Some mild or common side effects of sotalol include:

• Fatigue or weakness.
• Lightheadedness or dizziness.
• Slow heart rate (bradycardia).
• Shortness of breath (dyspnea).
• Headache.
• Nausea.

Some individuals may experience serious side effects while using Betapace. These adverse reactions may require immediate medical attention. If you experience any of the following, contact your healthcare provider or seek emergency medical help:

• QT prolongation or Torsade de pointes, a life-threatening arrhythmia.
• Severe bradycardia or heart block.
• Chest pain or signs of heart failure.
• Severe hypotension (low blood pressure).
• Masked symptoms of low blood sugar.
• Bronchospasm, especially in patients with asthma or emphysema.
• Allergic reactions such as hives, swelling, or trouble breathing.

These are not all of the possible side effects of Betapace. You should always seek medical advice from your healthcare provider for any questions or concerns about your medical condition or treatment. Read all patient information, medication guides, or package inserts that come with this medication. You can also report adverse effects to the Food and Drug Administration at www.fda.gov/medwatch or 1-800-FDA-1088.

Before starting Betapace, it is crucial to discuss any existing health conditions with your healthcare provider. You should be sure that your healthcare provider is aware of all your medical conditions, including:

• Long QT syndrome or a history of QT interval prolongation.
• Heart failure or reduced heart function.
• Heart disease.
• Sick sinus syndrome or AV block without a pacemaker.
• Kidney disease or reduced creatinine clearance.
• Low blood pressure or hypotension.
• Thyroid disorders.
• Diabetes or risk of hypoglycemia, as beta blockers can mask symptoms.
• Electrolyte imbalances such as low potassium (hypokalemia) or magnesium levels.
• Careful monitoring is required because Betapace increases the risk of proarrhythmia, especially during dose initiation.

Boxed Warning

Betapace has a boxed warning for proarrhythmic effects. Sotalol can cause life-threatening ventricular arrhythmias associated with QT prolongation, including torsade de pointes. Initiating therapy and dose adjustments should be performed in a setting that provides continuous ECG monitoring and assessment of kidney function.

Betapace is contraindicated in patients with:

• Baseline QT interval prolongation.
• Sinus bradycardia without a pacemaker.
• Cardiogenic shock or uncontrolled heart failure.
• Severe kidney impairment without appropriate dose adjustment.
• Known hypersensitivity to sotalol.

Betapace begins affecting heart rhythm within hours of dosing, but full stabilization may take several days. Monitoring is required during the early treatment period to ensure safe and effective rhythm control.

When Betapace is taken with other prescription drugs, over-the-counter medications, vitamins, and supplements, it may change how they work or increase the frequency or severity of side effects. Make sure that you tell your healthcare professional about anything that you are taking to avoid any negative drug interactions, including:

• Antacids containing magnesium hydroxide or aluminum, which reduce absorption.
• Amiodarone or other antiarrhythmic drugs, which increase the risk of QT prolongation.
• Digoxin, which may increase the risk of bradycardia.
• Calcium channel blockers, which may worsen heart block or low heart rate.
• Diuretics, which can cause electrolyte imbalances and increase arrhythmia risk.
• Supplements that affect potassium or magnesium levels.

Betapace is available as tablets and an oral solution.

Typical dosing based on source information includes:

Initial adult dosing often starts at 80 mg twice daily.

Doses may be increased gradually every three days if needed and tolerated.

Maximum doses depend on kidney function and ECG findings.

Pediatric dosing is individualized and based on weight and kidney function.

Dose adjustments are required for reduced creatinine clearance.

It should be stored at room temperature, away from the reach of children or pets.

Betapace is manufactured by Viatris.

Yes, sotalol hydrochloride is available as a generic medication.

Do not stop taking Betapace suddenly without medical advice. Abrupt discontinuation can cause an increased risk of worsening heart rhythm problems. Your healthcare provider may slowly reduce the dose if treatment needs to be stopped.

Talk to your doctor if you are already pregnant or if you have any plans to become pregnant. Betapace should only be used during pregnancy if the potential benefit outweighs the risk to the fetus.

Talk to your doctor if you are already breastfeeding or if you have any plans to breastfeed. Sotalol passes into breast milk and may affect the nursing infant. Your healthcare provider will help determine the safest option.